Judy Fox, PhD
Chief Development Officer
Dr. Judy Fox has over 25 years of experience in all phases of R&D with large and small molecule therapeutics for cancer and inflammatory diseases. She has a track record of program leadership that delivers rational, coherent and successful programs with specific expertise in Translational Sciences (bench to clinic to market).
Prior to Valorum, Dr. Fox worked as Chief Scientific Officer, Executive Vice President of R&D at Sunesis Pharmaceuticals. She has also held positions at Genentech, Genencor, and Chiron/Novartis. Dr. Fox received her Ph.D. in Biological Chemistry from the Massachusetts Institute of Technology, and an A.B. in Chemistry from Bryn Mawr College.